Galera Therapeutics is a biotechnology business based in the US. Galera Therapeutics shares (GRTX) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.02 – a decrease of 1.2% over the previous week. Galera Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.02 |
|---|---|
| 52-week range | $0.02 - $0.23 |
| 50-day moving average | $0.03 |
| 200-day moving average | $0.06 |
| Wall St. target price | $0.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.34 |
Historical closes compared with the close of $0.025 from 2025-04-24
| 1 week (2025-04-17) | 0.025 |
|---|---|
| 1 month (2025-03-26) | -26.47% |
| 3 months (2025-01-24) | -47.92% |
| 6 months (2024-10-25) | -56.14% |
| 1 year (2024-04-26) | -86.57% |
|---|---|
| 2 years (2023-04-26) | -99.10% |
| 3 years (2022-04-26) | 1.87 |
| 5 years (2020-04-24) | 12.76 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -48.81% |
| Return on equity TTM | -1063.11% |
| Profit margin | 0% |
| Book value | $-1.96 |
| Market Capitalization | $1.9 million |
TTM: trailing 12 months
We're not expecting Galera Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Galera Therapeutics's shares have ranged in value from as little as $0.021 up to $0.2345. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Galera Therapeutics's is 1.944. This would suggest that Galera Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Galera Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania. .
Track the progress of the S&P 500 stocks to make more informed investment decisions.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.